Drug
Who makes omalizumab?
2 companies list omalizumab as a human prescription drug, including under the names Xolair, Xolair PFS. Forms: injection, solution. Routes: subcutaneous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing omalizumab
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Genentech, Inc.United States | injection, solution | BLABLA103976 | 4 | 8 |
| Novartis Pharma Stein AG | injection, solution | DRUG FOR FURTHER PROCESSING | 4 | 0 |
Bulk ingredient listings
- Novartis Pharmaceuticals CorporationSwitzerland · 2 NDC
Enquiry
Common questions
- Who makes omalizumab?
- 2 companies list omalizumab as a human prescription drug in the openFDA NDC Directory, led by Genentech, Inc., Novartis Pharma Stein AG. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies omalizumab active ingredient?
- 1 company lists omalizumab as a bulk ingredient, including Novartis Pharmaceuticals Corporation.